Neonatal Vancomycin Trial

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The study aims to compare the efficacy, safety and pharmacokinetics (PK) of an optimised dosing to a standard dosing regimen of vancomycin in neonates and infants aged ≤ 90 days with late onset bacterial sepsis known or suspected to be caused by Gram-positive microorganisms
Epistemonikos ID: e76cd52186947851cd526a13d899be2af1359333
First added on: May 17, 2024